Influence of Blockade at Specific Levels of the Coagulation Cascade on Restenosis in a Rabbit Atherosclerotic Femoral Artery Injury Model

Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque.

1989 • 1,233 citations

Tissue factor and hemostasis [published erratum appears in Blood 1988 Apr;71(4):1178]

1988 • 941 citations

Minimally modified low density lipoprotein stimulates monocyte endothelial interactions.

1990 • 930 citations

Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins

1990 • 785 citations

Tissue factor and hemostasis [published erratum appears in Blood 1988 Apr;71(4):1178]

1988 • 670 citations

Balloon angioplasty. Natural history of the pathophysiological response to injury in a pig model.

1985 • 633 citations

Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock.

1993 • 552 citations

Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL.

1994 • 541 citations

Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor.

1993 • 506 citations

Randomized trial of intravenous heparin versus recombinant hirudin for acute coronary syndromes. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIa Investigators.

1994 • 505 citations

Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation

1993 • 505 citations

The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action

1988 • 482 citations

Mitogenic activity of blood components. I. Thrombin and prothrombin.

1975 • 481 citations

Differential sensitivity of erythrocyte-rich and platelet-rich arterial thrombi to lysis with recombinant tissue-type plasminogen activator. A possible explanation for resistance to coronary thrombolysis.

1989 • 473 citations

Hirudin in acute myocardial infarction. Safety report from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9A Trial.

1994 • 463 citations

Heparin induces release of extrinsic: Coagulation pathway inhibitor (EPI)

1988 • 401 citations

Mechanical strain induces growth of vascular smooth muscle cells via autocrine action of PDGF.

1993 • 368 citations

Time course of smooth muscle cell proliferation in the intima and media of arteries following experimental angioplasty.

1990 • 310 citations

Platelet accumulation in experimental angioplasty: time course and relation to vascular injury.

1987 • 296 citations

Initiation and regulation of tissue factor-dependent blood coagulation.

1992 • 287 citations

Amino acid sequence and posttranslational modifications of human factor VIIa from plasma and transfected baby hamster kidney cells

1988 • 270 citations

Initiation of Coagulation by Tissue Facto

1988 • 258 citations

797-1 Differential Expression of Tissue Factor Protein in Directional Atherectomy Specimens from Patients with Stable and Unstable Coronary Syndromes

1995 • 254 citations

Plasma antigen levels of the lipoprotein-associated coagulation inhibitor in patient samples

1991 • 239 citations

Minimally oxidized low-density lipoprotein induces tissue factor expression in cultured human endothelial cells.

1991 • 228 citations

Effectiveness of recombinant desulphatohirudin in reducing restenosis after balloon angioplasty of atherosclerotic femoral arteries in rabbits.

1991 • 223 citations

Tissue factor is rapidly induced in arterial smooth muscle after balloon injury.

1993 • 222 citations

A new digital electronic caliper for measurement of coronary arterial stenosis: Comparison with visual estimates and computer-assisted measurements

1984 • 212 citations

Purification and characterization of the lipoprotein-associated coagulation inhibitor from human plasma

1989 • 204 citations

Release of transforming growth factor-beta 1 from the pericellular matrix of cultured fibroblasts and fibrosarcoma cells by plasmin and thrombin.

1992 • 204 citations

Plasma antigen levels of the lipoprotein-associated coagulation inhibitor in patient samples

1991 • 202 citations

Coagulation factors X, Xa, and protein S as potent mitogens of cultured aortic smooth muscle cells.

1992 • 184 citations

Thrombin immobilized to extracellular matrix is a potent mitogen for vascular smooth muscle cells: nonenzymatic mode of action.

1990 • 167 citations

Measurement of basal levels of factor VIIa in hemophilia A and B patients [see comments]

1992 • 166 citations

Influence of inflation pressure and balloon size on the development of intimal hyperplasia after balloon angioplasty. A study in the atherosclerotic rabbit.

1989 • 165 citations

Activated factor VII: presence in factor IX concentrates and persistence in the circulation after infusion

1979 • 146 citations

Severity of peripheral atherosclerosis is associated with fibrinogen and degradation of cross-linked fibrin.

1993 • 135 citations

Conjunctive enhancement of enzymatic thrombolysis and prevention of thrombotic reocclusion with the selective factor Xa inhibitor, tick anticoagulant peptide. Comparison to hirudin and heparin in a canine model of acute coronary artery thrombosis.

1992 • 134 citations

Particle concentration fluorescence immunoassay (PCFIA): a new, rapid immunoassay technique with high sensitivity

1984 • 129 citations

Long-term biological response of injured rat carotid artery seeded with smooth muscle cells expressing retrovirally introduced human genes.

1994 • 124 citations

Prevention of arterial reocclusion after thrombolysis with recombinant lipoprotein-associated coagulation inhibitor.

1991 • 123 citations

Specific factor Xa inhibition reduces restenosis after balloon angioplasty of atherosclerotic femoral arteries in rabbits.

1994 • 110 citations

Comparison of the In Vivo Anticoagulant Properties of Standard Heparin and the Highly Selective Factor Xa Inhibitors Antistasin and Tick Anticoagulant Peptide (TAP) in a Rabbit Model of Venous Thrombosis

1991 • 107 citations

Mitochondrial function in the oxygen depleted and reoxygenated myocardial cell

1994 • 105 citations

Thrombin-induced release of active basic fibroblast growth factor- heparan sulfate complexes from subendothelial extracellular matrix

1993 • 95 citations

Uptake of exogenous free cholesterol induces upregulation of tissue factor expression in human monocyte-derived macrophages.

1992 • 83 citations

Regulation of endothelial cell tissue factor expression by minimally oxidized LDL and lipopolysaccharide.

1993 • 82 citations

Recombinant lipoprotein-associated coagulation inhibitor inhibits tissue thromboplastin-induced intravascular coagulation in the rabbit

1990 • 82 citations

The effects of thrombin on bovine aortic endothelial and smooth muscle cells

1990 • 76 citations

Binding of human factors VII and VIIa to a human bladder carcinoma cell line (J82)

1989 • 76 citations

Thrombin-induced release of active basic fibroblast growth factor- heparan sulfate complexes from subendothelial extracellular matrix

1993 • 72 citations

Fibrin formation and degradation in patients with arteriosclerotic disease.

1994 • 70 citations

Non-Fasting Factor VII Coagulant Activity (FVII:C) Increased by High-Fat Diet

1994 • 67 citations

Coagulation system activation and increase of D‐dimer levels in peripheral arterial occlusive disease

1993 • 57 citations

Enhanced procoagulatory activity (PCA) of human monocytes/macrophages after in vitro stimulation with chemically modified LDL

1989 • 56 citations

Refold and Characterization of Recombinant Tissue Factor Pathway Inhibitor Expressed in Escherichia coli

1994 • 54 citations

Clearance of Recombinant Tissue Factor Pathway Inhibitor (TFPI) in Rabbits

1992 • 52 citations

Recombinant Desulphatohirudin (CGP 39393) Anticoagulant and Antithrombotic Properties In Vivo

1989 • 52 citations

Activated factor X and thrombin formation triggered by tissue factor on endothelial cell matrix in a flow model: effect of the tissue factor pathway inhibitor

1994 • 44 citations

Role of High-Affinity Thrombin Receptors in Postclotting Cellular Effects of Thrombin

1992 • 41 citations

[11] Tissue factor pathway inhibitor

1993 • 41 citations

Maintenance of canine coronary artery patency following thrombolysis with front loaded plus low dose maintenance conjunctive therapy. A comparison of factor Xa versus thrombin inhibition

1994 • 41 citations

Development of Recombinant Hirudin as a Therapeutic Anticoagulant and Antithrombotic Agent: Some Objective Considerations

1989 • 38 citations

Anticoagulant and Antithrombotic Actions of Recombinant Hirudin

1991 • 25 citations

Hypercoagulability and Factor VII in Hypertriglyceridemia

1988 • 23 citations

Contribution of platelets and the vessel wall to the antithrombotic effects of a single bolus injection of Fab fragments of the antiplatelet GPIIb/IIIa antibody 7E3 in a canine arterial eversion graft preparation.

1994 • 15 citations

Hyperlipidemia and in vivo Hemostatic System Activation

1988 • 10 citations

The Animal Welfare Act of 1970

1971 • 6 citations